BSNXD modulates mesenchymal stem cell differentiation into osteoblasts in a postmenopausal osteoporotic mouse model

Area of Science:

• Biomedical Science
• Stem Cell Biology
• Traditional Chinese Medicine

Background:

• Mesenchymal stem cells (MSCs) differentiate into osteoblasts and adipocytes.
• Imbalances in MSC differentiation, favoring adipocytes over osteoblasts, are linked to postmenopausal osteoporosis (PMO).
• BuShen NingXin Decoction (BSNXD) is a traditional Chinese medicinal compound with potential therapeutic applications.

Purpose of the Study:

• To investigate whether BSNXD regulates MSC differentiation into osteoblasts and adipocytes.
• To evaluate the effects of BSNXD on bone morphometry and immune cell populations in vivo.
• To elucidate the molecular mechanisms underlying BSNXD's action on MSC differentiation.

Main Methods:

• Micro-computed tomography (micro-CT) for bone morphometry.
• Flow cytometry (FCM) for immune cell analysis.
• In vitro assays including Alkaline Phosphatase (ALP) staining, Oil Red O staining, and real-time PCR for gene expression analysis.

Main Results:

• BSNXD increased bone volume, bone mineral density, and bone trabecular number, while decreasing spacing.
• BSNXD treatment enhanced regulatory T cell (Treg) function in vivo.
• In vitro, BSNXD promoted osteoblast differentiation markers (ALP, Collagen I, Osteocalcin, Runx2, Osterix) and suppressed adipocyte differentiation markers (PPARγ).

Conclusions:

• BSNXD promotes osteoblastogenesis and inhibits adipogenesis from MSCs.
• BSNXD positively influences bone health and immune regulation, potentially via modulating MSC differentiation.
• BSNXD demonstrates potential efficacy in preventing postmenopausal osteoporosis.